Interaction with Academia
The group maintains collaborations with several research centres, universities and polytechnic institutes:
Cochrane Portugal ( ISBE -Prof Vaz Carneiro) and Cochrane Coimbra (IBILI- Prof Miguel Castelo Branco) . Both centers provide support in the creation of the Associate Center for Systematic reviews of literature of UBI ( GRUBI).
Instituto Politécnico de Castelo Branco, Instituto Politécnico da Guarda and Instituto Politécnico de Viseu through the AgeINfuture Association- European center for active and healthy aging. The four academic institutions are providing together, research in aging, dissemination of good practices and support in changes toward active and healthy aging.
António Salgado, Universidade do Minho, ICVS- Collaboration in studies on the potential of the stem cell secretome in ischemic diseases.
CIBB-Center for Innovative Biomedicine and Biotechnology, University of Coimbra, Coimbra, Portugal
António Martinho, Laboratório de Genética Molecular, Centro de Sangue e da Transplantação de Coimbra, Coimbra (HLA genotyping)
Artur Paiva, Unidade de Gestão Operacional de Citometria, Serviço de Patologia Clínica, Centro Hospitalar e Universitário de Coimbra (flow cytometry acquisition)
Armindo Salvador, Center for Neuroscience and Cell Biology, University of Coimbra;CQC, Department of Chemistry, University of Coimbra
Bruno Manadas, Universidade de Coimbra, CNC- Co-supervision of students and participation in joint projects in the area of hypoxic ischemic encephalopathy
Margarida Castro, Faculty of Science and Technology; CQC, Coimbra Chemistry Center, University of Coimbra, Coimbra, Portugal
Carlos Geraldes, Faculty of Science and Technology; CQC, Coimbra Chemistry Center,University of Coimbra, Coimbra, Portugal
Lino Ferreira, Faculty of Medicine, University of Coimbra - development of drug delivery systems targeting brain diseases.
Ramiro Almeida, Universidade de Aveiro, IbiMed- Co-supervision of students and collaboration in studies on the role of STEP in synapse formation.
Iola Duarte, CICECO-Aveiro Institute of Materials and Department of Chemistry, University of Aveiro
Ana M. Gil, CICECO-Aveiro Institute of Materials and Department of Chemistry, University of Aveiro
Mara Freire, CICECO - Aveiro Institute of Materials, University of Aveiro
João Fonseca-Gomes, Institute of Pharmacology and Neurosciences, Faculty of Medicine, University of Lisbon, Lisbon
Ana Maria Sebastião, Faculty of Medicine, University of Lisbon; Institute of Molecular Medicine, University of Lisbon in relation to the studies of cannabinoid receptors
Maria J Diógenes, Institute of Pharmacology and Neurosciences, Faculty of Medicine,University of Lisbon, Lisbon
Simão Rocha, Institute for Molecular Medicine (IMM), Lisboa
Knowledge Transfer actions (Interaction with Industry)
Patent transfer -IPR licensed to the company Fastprinciple;
Pre-clinical validation of a new therapeutic approaches to slow down Parkinson’s disease progression.
Clinical interactions
Serviço de Nefrologia do Hospital Amato Lusitano, Castelo-Branco (collection of human samples and clinical data)
• Centro Hospitalar e Universitário de Coimbra, Coimbra
• Coimbra Institute for Clinical and Biomedical Research (iCBR), Faculty of Medicine,
University of Coimbra
• Fátima Paiva, Stroke Unit, Cova da Beira Hospital Center, Covilhã
• Jorge Martinez, Immunohemotherapy Service, Cova da Beira Hospital Center, Covilhã
• Carmen Jerónimo, Research Center of Portuguese Oncology Institute of Porto (GEBC CI-IPOP)
Outreach activites
● Participation in the Brain Awareness week
● Since 2020 two members of NND are part of AgeInfuture, an Association recognized as an european centre for Active and healthy aging, with the purpose of improving healthy and active aging, but also to promote and apply research in aging. This association has already 100 partners and includes several municipalities, patients associations, health providers and social groups related to aging .
● 2022: Workshop: "New Parkinson's Therapies", integrado no XIII Beira Interior Medical Meeting, 12 de fevereiro.
● 2022: Participation on the Science and Technology Week at the Health Sciences Research Center, CICS-UBI, with the activity entitled: “O cérebro a Última fronteira”. High school students from the Beira Interior region visited CICS-UBI's facilities where they interacted directly with researchers and participated in lectures and experimental activities, deepening they knowledge about brain structure and functioning.
● 2022: Interview for SIC Television news: https://sicnoticias.pt/saude-e-bem-estar/novo-medicamento-para-parkinson-desenvolvido-na-faculdade-de-ciencias-da-saude-na-covilha/
● 2022: Interview for TVI/CNN Television news: Esta Manhã - 8 de junho de 2022 | Esta manhã | TVI Player (iol.pt) minute 1.10.20 a 1.12.55-Explaining the development of PDSolve project and NeuroSoV.
● 2022: Interview for Portuguese Television (RTP), program: “Portugal em Direto). More on: Portugal em Direto de 06 Jun 2022 - RTP Play - RTP minute 4.28 ao 17.24
● Explaining the NeuroSoV project, PDSolve, and its importance for Parkinson’s patients and of the the Research made at CICS-UBI in this field.
Internationalisation
Bolsa UNITA to collaborate with Alessandro Vercelli/ Ferdinando di Cunto in the frame of project “Digital effects in health prevention of older people of the Interior Centre of Beira Interior - Portugal”
Universidade de S. Paulo- Glaucia Pivi- collaboration in a research envolving Nutricional changes due to Covid 19
Project financed by Turim University (UniTo), to collaborate with Serena Stanga (Department of Neuroscience, Neuroscience Institute Cavalieri Ottolenghi (NICO), of the University of Turin) in the project entitled "New strategy to prevent the progression of neurodegeneration occurring in Alzheimer’s Disease”.
Project financed by Turim University (UniTo), to collaborate with Elisabetta Marini (researcher at the Department of Drug Science and Technology of the University of Turin) in the project entitled "Development of new inflammasome inhibitors for parkinson’s disease therapy”.
Project financed by Turim University (UniTo), to collaborate with Marina Boido (researcher at the Department of Neuroscience, Neuroscience Institute Cavalieri Ottolenghi (NICO), of the University of Turin) in the project entitled "New strategy to prevent the progression of neurodegeneration occurring in Amyotrophic Lateral Sclerosis”.
José Cipolla-Neto, Department of Physiology and Biophysics, Neurobiology Lab, University of São Paulo - collaboration on melatonin and its effect in the choroid plexus circadian clock (Telma Quintela)
Christian Schwerk, Childrens Hospital, Medical Faculty Mannheim, Heidelberg University, Germany. Consórcio Complexus (H2020)- collaboration on the analysis of transport across the blood-cerebrospinal fluid barrier (Cecília Santos)
Isidro Ferrer, Barcelona, Spain to provide samples of human choroid plexus and glioblastoma samples (Cecília Santos)
Jens Pahnke. Department of Translational Neurodegeneration Research and Neuropathology, University of Oslo, Norway. Projeto Transport Dementia, Consortium Brain Senses (Cecília Santos), collaboration in research on ABC transporters
Robert Pressner, Charité Berlin, Consortium Brain Senses (Cecília Santos), research on the identification of taste receptors ligands (Cecília Santos)
Markus Uhrberg, Institute for Transplantation Diagnostics and Cell Therapeutics, Medical Faculty, Heinrich-Heine University Düsseldorf, Düsseldorf, Germany to investigate Signaling Pathways and Transcriptional Identities in Human CD8+ T Cells with an Effector-Memory Phenotype: Implications for Cognitive Impairment in the Elderly (Elsa Cardoso, Fernando Arosa)
Gonçalo Graça, Faculty of Medicine, Imperial College London, London, UK
Instituto de Investigación Sanitaria Galicia Sur in the scope of “Rede Galega de Investigación en demencias (RGID)” Jean Bousquet, University Hospital of Montpellier, INSERM U1168, France; studies on de ARIA-MEDAL hyopothesis on new insights into the links between polysensitization and multimorbidity and ongoing projecs in mHealth supporting the definition of novel allergic phenotypes (Olga Lourenço)
Jens Christian Schwamborn, University of Luxembourg, Luxembourg - to evaluate the therapeutic effects of microRNAs in midbrain organoids.
Ruberte París, PATHBIO – Precision Pathobiology for Disease Models, Center for Animal Biotechnology and Gene Therapy (CBATEG), Spain.
Sinthia Bosnic-Anticevich, University of Sidney, Australia; development of a PSA Respiratory Task Force on shared decision making in respiratory diseases bringing together evidence about different treatment options and a patient-centred perspective to make optimal treatment decisions. (Olga Lourenço)
Yoon-Seong Kim, Rutgers Robert Wood Johnson Medical School, NJ, USA
Ignacio Lizasoain, School of Medicine of Universidad Complutense in Madrid. Co-supervision of students and participation in funding applications for projects in the area of ischemic stroke.